![Genentech banner](/sites/default/files/styles/x_large/public/2024-09/Genentech-1.jpg?itok=2rZb6d8J)
Genentech buys Regor's next-gen CDK inhibitors for $850M
Regor Therapeutics Group has agreed to sell its portfolio of CDK inhibitors to Roche's Genentech for an upfront cash payment of $850 million.
![Chiesi Group HQ](/sites/default/files/styles/x_large/public/2024-09/Chiesi-HQ-image_0.jpg?itok=yH5I24R7)
Chiesi Biotech Center of Excellence opens to strengthen R&D ...
Chiesi Group has today officially launched its new Biotech Center of Excellence, with the aim that it "brings the future of medicine to Parma."
![Cassava Sciences logo](/sites/default/files/styles/x_large/public/2024-09/Cassava_logo.jpg?itok=vIl7r53u)
SEC charges Cassava over 'misleading' Alzheimer's claims
The US financial regulator has accepted a $40 million-plus settlement from Cassava Sciences and two of its former executives for making what it alleges are misleading statements about the r
![Dupixent](/sites/default/files/styles/x_large/public/2024-09/Dupixent-pen_1.jpg?itok=xpNPzXzN)
Sanofi's Dupixent scores double COPD win in US, China
Originally anticipated in June, the FDA action stands to make Sanofi and Regeneron's biologic blockbuster even bigger.
![Roche's PNH drug PiaSky backed for NHS use by NICE](https://pharmaphorum.com/sites/default/files/styles/x_large/public/2023-10/Roche_logo.jpg?itok=-fpSgFk6)
Roche's PNH drug PiaSky backed for NHS use by NICE
Roche's PiaSky has been recommended for use by the NHS in England and Wales for the rare blood disorder paroxysmal nocturnal haemoglobinuria (PNH), becoming the first option for patients th
Editor's Picks
Editor's Picks
Partner Content
![FT Global Pharma & Biotech Summit 2024 banner](/sites/default/files/styles/x_large/public/2024-09/Newsletter%2520%2526%2520Event%2520Listing.jpg?itok=Mn7Fp6y-)
FT Global Pharma & Biotech Summit 2024
The Global Pharma and Biotech Summit is the essential annual event for you to stay on top of the latest trends and innovations in life sciences.
![7th RNA-Targeted Drug Discovery & Development Summit banner](/sites/default/files/styles/x_large/public/2024-09/47843-7th%20RNA-Targeted-Drug-Discovery-and-Development-Summit.jpg?itok=6chIw3GK)
7th RNA-Targeted Drug Discovery & Development Summit
Optimizing Lead Discovery, Structural Analysis & Preclinical Modeling to Successfully Develop Stable, Effective & Orally Bioavailable Small Molecule RNA Drugs for Robust Translation
![9th CDD For Biologics Summit 2024 banner](/sites/default/files/styles/x_large/public/2024-09/47703-9th-CDD-For-Biologics-Summit-2024.jpg?itok=m5Z5JIiQ)
9th CDD For Biologics Summit 2024
Integrate Computational Biology, Generative AI & Machine Learning to Revolutionize Biologics Drug Discovery & Development
![Targeted Radiopharmaceuticals Summit EU 2024 image banner](/sites/default/files/styles/x_large/public/2024-09/TRP-EU.jpg?itok=Z09jM9Zc)
Targeted Radiopharmaceuticals Summit EU 2024
Taking place in Amsterdam 3rd- 5th December! With 40+ new speakers, 2 tracks of content (pre-clinical and clinical), a deep dive workshop day
![4th Mitochondrial Dysfunction Drug Development Summit banner image](/sites/default/files/styles/x_large/public/2024-09/4th-Mitochondrial-Dysfunction-Drug-Development-Summit-banner.jpg?itok=cbiFUWIQ)
4th Mitochondrial Dysfunction Drug Development Summit
Uncover mitochondrial pathogenic mechanisms to show clinical efficacy for regulatory success